Recordati Group
Clinical trials sponsored by Recordati Group, explained in plain language.
-
Tracking a Cushing's syndrome drug in Real-World patients for 3 years
Disease control OngoingThis study is observing patients with Cushing's syndrome who are already taking the medication osilodrostat in their regular care. Researchers will follow about 200 patients for up to 3 years to collect information on the drug's long-term safety and how well it works to control t…
Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New injection tested to stop dangerous sugar crashes after bariatric surgery
Disease control OngoingThis study is testing if an injectable medication called pasireotide can help control severe low blood sugar episodes that sometimes occur after weight-loss surgery. About 93 adults who experience these episodes despite dietary changes will test one of three doses or a placebo fo…
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC